Boiko et al identified that CD271+ melanoma cells lacked the expression of TYR, MART1 and MAGE genes in 86, 69 and 68% of melanoma patients, respectively, which may explain the reason for T-cell therapies targeting these antigens usually resulting in only temporary tumor shrinkage (16). The gene discussed is TYR; the disease is neoplasm.